◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

The United Laboratories International Holdings Limited (3933) Financial History

Name: The United Laboratories International Holdings Limited (3933) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

The United Laboratories International Holdings Limited (3933) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Yuen Long, Hong Kong with about 18,000 employees. Its market capitalization is roughly CNY 18 billion. In the fiscal year ended 2025-12-31, 3933 reported CNY 13.2B in revenue and CNY 2.1B in net income.

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products.

Interactive charts & full statements →

3933 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	CNY 13.2B	CNY 13.8B	CNY 13.7B	CNY 11.3B
Gross Profit	CNY 5.5B	CNY 6.1B	CNY 6.3B	CNY 5.0B
Operating Income (EBIT)	CNY 2.5B	CNY 3.1B	CNY 3.3B	CNY 2.1B
Net Income	CNY 2.1B	CNY 2.7B	CNY 2.7B	CNY 1.6B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3933 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(CNY 1.0B)	(CNY 1.0B)	(CNY 581M)	(CNY 273M)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3933 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 30.9B	CNY 25.8B	CNY 21.0B	CNY 19.0B	—
Total Liabilities	CNY 13.4B	CNY 11.4B	CNY 8.3B	CNY 8.4B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3933 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

1513 · Livzon Pharmaceutical Group Inc. — $23 billion
6887 · Sunshine Lake Pharma Co., Ltd. — $20 billion
0512 · Grand Pharmaceutical Group Limited — $19 billion
4538 · Fuso Pharmaceutical Industries,Ltd. — $19 billion
0013 · HUTCHMED (China) Limited — $17 billion
2929 · Pharma Foods International Co., Ltd. — $17 billion
2637 · Fujian Haixi Pharmaceuticals Co., Ltd. — $15 billion
IPN · Ipsen S.A. — $13 billion

← 3932 All “0-9” companies 3934 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.